Antiarrhythmic Effects of N-3 Fatty Acids
NCT00004558 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2016-02-18
Summary
To determine the antiarrhythmic effects of dietary N-3 fatty acids in patients with implanted defibrillators.
Conditions
- Arrhythmia
- Heart Diseases
- Tachycardia, Ventricular
- Ventricular Fibrillation
Interventions
- BEHAVIORAL
-
dietary n-3 polyunsaturated fatty acids
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-02-28
- Completion
- 2004-01-31
More Related Trials
-
Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial
NCT00290056 ·Status: UNKNOWN ·Phase: PHASE4
-
Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia
NCT00507390 ·Status: WITHDRAWN ·Phase: PHASE4
-
n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
NCT01198275 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of the Prevention of Atrial Fibrillation by ALA
NCT00410839 ·Status: UNKNOWN ·Phase: PHASE2
-
Arrhythmia Prevention With an Alpha-Linolenic Enriched Diet
NCT00410020 ·Status: COMPLETED ·Phase: PHASE2
-
Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation
NCT01235130 ·Status: COMPLETED ·Phase: PHASE3
-
PUFAs and Left Ventricular Function in Heart Failure
NCT01223703 ·Status: COMPLETED ·Phase: PHASE3
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Different Types of Fatty Acid on Risk Factors for Heart Disease
NCT01351324 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
NCT00970489 ·Status: COMPLETED ·Phase: PHASE3
-
Nutrition Intervention to Decrease Symptoms in Patients With Heart Failure
NCT01733017 ·Status: COMPLETED ·Phase: PHASE2
-
SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia
NCT00110838 ·Status: COMPLETED ·Phase: PHASE3
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
NCT03372733 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Effectiveness of Fish Oil Supplements at Reducing the Recurrence of Atrial Fibrillation
NCT00552084 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Stearidonic Acid-Containing Foods on Eicosapentaenoic Acid Levels in Red Blood Cells and Omega-3 Index
NCT01749202 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
NCT00232219 ·Status: COMPLETED ·Phase: PHASE4
-
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
NCT00149409 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of 12 wk of Omega-3 FA Supplementation on Metabolic and Physical Health Parameters in Older Adults
NCT01734538 ·Status: UNKNOWN ·Phase: NA
-
Effects of Fish Oil on Post Ablation Arrhythmias
NCT00791089 ·Status: TERMINATED ·Phase: PHASE4
-
The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors
NCT00266292 ·Status: UNKNOWN ·Phase: NA
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Healthy Fatty Acids in Transition
NCT00937963 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturates and KCL to Control Mild Hypertension
NCT00000511 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation
NCT00597220 ·Status: UNKNOWN ·Phase: PHASE3